News Opinion Editor's Corner ACC 2016 Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016 Shelley Wood April 13, 2016
News Daily News Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV Michael O'Riordan December 15, 2015
News Daily News Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee Michael O'Riordan December 15, 2015
News Daily News Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR Todd Neale July 27, 2015